Hyperbaric Oxygen Therapy (HBOT) is a clinical treatment where the patient breathes 100% oxygen intermittently while enclosed in a hyperbaric oxygen chamber at a pressure greater than one atmosphere.

​

HBOT has been proven effective for many medical conditions, and as a result the Undersea and Hyperbaric Medicine Society, one of the premier research institutes, has approved it to treat the following indications:

​

• Air or Gas Embolism

• Carbon Monoxide Poisoning, Carbon Monoxide Poisoning Complicated by Cyanide Poisoning

• Clostridal Myositis and Myonecrosis (Gas Gangrene)

• Crush Injury, Compartment Syndrome, and other Acute Traumatic Ischemias

• Decompression Sickness

• Enhancement of Healing in Selected Problem Wounds

• Severe Anemia

• Necrotizing Soft Tissue Infections

• Refractory Osteomyelitis

• Delayed Radiation Injury (Soft Tissue and Bony Necrosis)

• Compromised Skin Grafts & Flaps

 

In addition, Medicare coverage determinations will reimburse in the U.S. for the following conditions :

• Patient has type I or type II diabetes and has a lower extremity wound that is due to diabetes;

• Patient has a wound classified as Wagner grade III or higher; and

• Patient has failed an adequate course of standard wound therapy.

• Acute Thermal Burn Injury